-
Something wrong with this record ?
Polymorphism rs11867353 of Tyrosine Kinase Non-Receptor 1 (TNK1) Gene Is a Novel Genetic Marker for Alzheimer's Disease
T. Zeman, VJ. Balcar, K. Cahová, J. Janoutová, V. Janout, J. Lochman, O. Šerý
Language English Country United States
Document type Journal Article
NLK
ProQuest Central
from 1997-02-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2010-02-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-02-01 to 1 year ago
Psychology Database (ProQuest)
from 1997-02-01 to 1 year ago
- MeSH
- Alzheimer Disease genetics MeSH
- Fetal Proteins genetics MeSH
- Genetic Predisposition to Disease * MeSH
- Genetic Association Studies MeSH
- Genetic Markers MeSH
- Body Mass Index MeSH
- Polymorphism, Single Nucleotide genetics MeSH
- Cognitive Dysfunction diagnosis genetics MeSH
- Humans MeSH
- Aged MeSH
- Case-Control Studies MeSH
- Body Weight MeSH
- Body Height MeSH
- Protein-Tyrosine Kinases genetics MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Several single-nucleotide polymorphisms (SNPs) and rare variants of non-receptor tyrosine kinase 1 gene (TNK1) have been associated with Alzheimer's disease (AD). To date, none of the associations have proven to be of practical importance in predicting the risk of AD either because the evidence is not conclusive, or the risk alleles occur at very low frequency. In the present study, we are evaluating the associations between rs11867353 polymorphism of TNK1 gene and both AD and mild cognitive impairment (MCI) in a group of 1656 persons. While the association with AD was found to be highly statistically significant (p < 0.0001 for the risk genotype CC), no statistically significant association with MCI could be established. Possible explanation of the apparent discrepancy could be rapid progression of MCI to AD in persons with the CC genotype. Additional findings of the study are statistically significant associations of rs11867353 polymorphism with body mass index, body weight, and body height. The patients with AD and CC genotype had significantly lower values of body mass index and body weight compared with patients with other genotypes. The main outcome of the study is the finding of a previously never described association between the rs11867353 polymorphism of the TNK1 gene and AD. The rs11867353 polymorphism has a potential to become a significant genetic marker when predicting the risk of AD.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004587
- 003
- CZ-PrNML
- 005
- 20220127145134.0
- 007
- ta
- 008
- 220113s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12035-020-02153-4 $2 doi
- 035 __
- $a (PubMed)33070267
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Zeman, Tomáš $u Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Veveří 97, 602 00, Brno, Czech Republic
- 245 10
- $a Polymorphism rs11867353 of Tyrosine Kinase Non-Receptor 1 (TNK1) Gene Is a Novel Genetic Marker for Alzheimer's Disease / $c T. Zeman, VJ. Balcar, K. Cahová, J. Janoutová, V. Janout, J. Lochman, O. Šerý
- 520 9_
- $a Several single-nucleotide polymorphisms (SNPs) and rare variants of non-receptor tyrosine kinase 1 gene (TNK1) have been associated with Alzheimer's disease (AD). To date, none of the associations have proven to be of practical importance in predicting the risk of AD either because the evidence is not conclusive, or the risk alleles occur at very low frequency. In the present study, we are evaluating the associations between rs11867353 polymorphism of TNK1 gene and both AD and mild cognitive impairment (MCI) in a group of 1656 persons. While the association with AD was found to be highly statistically significant (p < 0.0001 for the risk genotype CC), no statistically significant association with MCI could be established. Possible explanation of the apparent discrepancy could be rapid progression of MCI to AD in persons with the CC genotype. Additional findings of the study are statistically significant associations of rs11867353 polymorphism with body mass index, body weight, and body height. The patients with AD and CC genotype had significantly lower values of body mass index and body weight compared with patients with other genotypes. The main outcome of the study is the finding of a previously never described association between the rs11867353 polymorphism of the TNK1 gene and AD. The rs11867353 polymorphism has a potential to become a significant genetic marker when predicting the risk of AD.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a Alzheimerova nemoc $x genetika $7 D000544
- 650 _2
- $a tělesná výška $7 D001827
- 650 _2
- $a index tělesné hmotnosti $7 D015992
- 650 _2
- $a tělesná hmotnost $7 D001835
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a kognitivní dysfunkce $x diagnóza $x genetika $7 D060825
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fetální proteiny $x genetika $7 D005326
- 650 _2
- $a genetické asociační studie $7 D056726
- 650 _2
- $a genetické markery $7 D005819
- 650 12
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a jednonukleotidový polymorfismus $x genetika $7 D020641
- 650 _2
- $a tyrosinkinasy $x genetika $7 D011505
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Balcar, Vladimir J $u Bosch Institute and Discipline of Anatomy and Histology, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia
- 700 1_
- $a Cahová, Kamila $u Laboratory of Neurobiology and Molecular Psychiatry, Department of Biochemistry, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
- 700 1_
- $a Janoutová, Jana $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Janout, Vladimír $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Lochman, Jan $u Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Veveří 97, 602 00, Brno, Czech Republic $u Laboratory of Neurobiology and Molecular Psychiatry, Department of Biochemistry, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
- 700 1_
- $a Šerý, Omar $u Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Veveří 97, 602 00, Brno, Czech Republic. omarsery@sci.muni.cz $u Laboratory of Neurobiology and Molecular Psychiatry, Department of Biochemistry, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. omarsery@sci.muni.cz
- 773 0_
- $w MED00005280 $t Molecular neurobiology $x 1559-1182 $g Roč. 58, č. 3 (2021), s. 996-1005
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33070267 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145131 $b ABA008
- 999 __
- $a ok $b bmc $g 1751901 $s 1155736
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 58 $c 3 $d 996-1005 $e 20201018 $i 1559-1182 $m Molecular neurobiology $n Mol Neurobiol $x MED00005280
- LZP __
- $a Pubmed-20220113
